Aktuelle Neurologie, Table of Contents Aktuelle Neurologie 2014; 41(07): 421-422DOI: 10.1055/s-0034-1387210 Kompetenznetz Multiple Sklerose © Georg Thieme Verlag KG Stuttgart · New York Aktuelles aus der Forschung M. S. Weber 1 Institut für Neuropathologie und Klinik für Neurologie, Georg-August-Universität, Göttingen , I. Kleiter 2 Klinik für Neurologie, St. Josef-Hospital, Ruhr-Universität Bochum › Author Affiliations Recommend Article Abstract Buy Article Full Text References Literatur 1 Polman CH et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011; 69: 292-302 2 Lublin FD et al. Defining the clinical course of multiple sclerosis: The 2013 revisions. Neurology 2014; 83: 278-286 3 Lublin FD et al. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996; 46: 907-911 4 Hawker K et al. Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial. Ann Neurol 2009; 66: 460-471 5 Villar LM et al. Immunoglobulin M oligoclonal bands: Biomarker of targetable inflammation in primary progressive multiple sclerosis. Ann Neurol 2014; Jun 6. 6 Villar LM et al. Intrathecal IgM synthesis is a prognostic factor in multiple sclerosis. Ann Neurol 2003; 53: 222-226 7 Cruz-Orengo L et al. Enhanced sphingosine-1-phosphate receptor 2 expression underlies female CNS autoimmunity susceptibility. J Clin Invest 2014; 124: 2571-2584
